Capital eventCH·7d ago✦ enriched
ADC Therapeutics raises $86.6M to fund lymphoma trials, extend runway to 2029 | Dealroom News
ADC Therapeutics raised $86.6 million in a private placement, led by Bain Capital Life Sciences, to fund lymphoma trials and extend runway to 2029, with participation from existing backers Redmile and TCGX.
WARM· 56intent / 100
▸ why this score▾ score breakdown
- default: P(contract_to_capital_90d) · p=0.39 × w=3.0+1.2
- default: OON discount · × 0.75-0.4
- Final score (ambiguity-dampened) · default=56+56
- V2 winner: default · default=56+0